People with two subtypes of adenocarcinoma of the lung, adenocarcinoma in situ and minimally invasive adenocarcinoma have a better outcome, especially when the cancer is treated early with surgery.

rates as patients with adenocarcinoma in-situ (AIS), according to research. Lung cancer patients with minimally invasive adenocarcinoma (MIA) have similar, positive five-year disease-free survival ...

37,38 Similarly, patients with ductal carcinoma in situ that is diagnosed on core needle biopsy require surgical excision to remove the ductal carcinoma in situ and rule out associated invasive ...